While there are limitations to this study (respondents over childbearing age, white, educated, insured), within 2 months of @USSupremeCourt3's overturn of Roe v Wade, 1 in 17 MTX pts experienced a barrier to getting rx filled. ABS L09 @RheumNow #ACR22 https://t.co/WuikwO1bZ9 https://t.co/4Ve0zAVxbG
Links:
Impact on Access to Methotrexate in the Post-Roe Era - ACR Meeting Abstracts
http://ow.ly/GWY650LpF0W
14-11-2022